View full page
Articles published electronically 2/3/10
Efficacy of the Novel Antidepressant Agomelatine
on the Circadian Rest-Activity Cycle and
Depressive and Anxiety Symptoms in
Patients With Major Depressive Disorder:
A Randomized, Double-Blind Comparison With Sertraline. Siegfried Kasper, MD, PhD; Göran Hajak, MD; Katharina Wulff, PhD;
Witte J. G. Hoogendijk, MD, PhD; Angel Luis Montejo, MD, PhD;
Enrico Smeraldi, MD; Janusz K. Rybakowski, MD;
Maria-Antonia Quera-Salva, MD; Anna M. Wirz-Justice, PhD;
Françoise Picarel-Blanchot, PhD; and Franck J. Baylé, MD
[Abstract/Purchase] [Full Text] Posted
2/3/10
Articles published electronically 1/26/10
Does Inclusion of a Placebo Arm Influence Response to Active Antidepressant Treatment in Randomized Controlled Trials? Results From Pooled and Meta-Analyses. Mark Sinyor, MD; Anthony J. Levitt, MD; Amy H. Cheung, MD; Ayal Schaffer, MD; Alex Kiss, PhD; Yekta Dowlati, MSc; and Krista L. Lanctôt, PhD
[Abstract/Purchase] [Full Text] Posted
1/26/10
A Double-Blind, Placebo-Controlled Study of Quetiapine and Lithium Monotherapy in Adults in the Acute Phase of Bipolar Depression (EMBOLDEN I). Allan H. Young, FRCPsych; Susan L. McElroy, MD;
Michael Bauer, MD, PhD; Nabil Philips, MD; William Chang, PhD;
Bengt Olausson, MD; Björn Paulsson, MD; and Martin Brecher, MD;
for the EMBOLDEN I (Trial 001) Investigators
[Abstract/Purchase] [Full Text] Posted
1/26/10
A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II). Susan L. McElroy, MD; Richard H. Weisler, MD;
William Chang, PhD; Bengt Olausson, MD; Björn Paulsson, MD;
Martin Brecher, MD; Vasavan Agambaram, MD; Charles Merideth, MD;
Arvid Nordenhem, MD; and Allan H. Young, FRCPsych;
for the EMBOLDEN II (Trial D1447C00134) Investigators
[Abstract/Purchase] [Full Text] Posted
1/26/10
The Effect of Ondansetron, a 5-HT3 Receptor Antagonist, in Chronic Fatigue Syndrome: A Randomized Controlled Trial. Gerard K. H. The, MD; Gijs Bleijenberg, PhD;
Jan K. Buitelaar, MD, PhD; and Jos W. M. van der Meer, MD, PhD, FRCP
[Abstract/Purchase] [Full Text] Posted
1/26/10
Psychiatrists’ and Nonpsychiatrist Physicians’ Reported Use of the DSM-IV Criteria for Major Depressive Disorder. Mark Zimmerman, MD, and Janine Galione, BS
[Abstract/Purchase] [Full Text] Posted
1/26/10
The Effect of Moderate and Excessive Alcohol Use on the Course and Outcome of Patients With Bipolar Disorders: A Prospective Cohort Study. J. van Zaane, MD; W. van den Brink, MD, PhD;
S. Draisma, PhD; J. H. Smit, PhD; and W. A. Nolen, MD, PhD
[Abstract/Purchase] [Full Text] Posted
1/26/10
Neurocognitive Functioning as Intermediary Phenotype and Predictor of Psychosocial Functioning Across the Psychosis Continuum: Studies in Schizophrenia and Bipolar Disorder. Nienke Jabben, MSc; Baer Arts, MD;
Jim van Os, MD, PhD; and Lydia Krabbendam, PhD
[Abstract/Purchase] [Full Text] Posted
1/26/10
Telemedicine for Anger Management Therapy in a Rural Population of Combat Veterans With Posttraumatic Stress Disorder: A Randomized Noninferiority Trial. Leslie A. Morland, PsyD; Carolyn J. Greene, PhD; Craig S. Rosen, PhD;
David Foy, PhD; Patrick Reilly, PhD; Jay Shore, MD, MPH;
Qimei He, PhD; and B. Christopher Frueh, PhD
[Abstract/Purchase] [Full Text] Posted
1/26/10
Ziprasidone Plus a Mood Stabilizer in Subjects With Bipolar I Disorder: A 6-Month, Randomized, Placebo-Controlled, Double-Blind Trial. Charles L. Bowden, MD; Eduard Vieta, MD; Kathleen S. Ice, PhD;
Jeffrey H. Schwartz, PhD; Paul P. Wang, MD; and Mark Versavel, MD
[Abstract/Purchase] [Full Text] Posted
1/26/10
Articles published electronically 1/12/10
Categorical and Dimensional Stability of Comorbid Personality Disorder Symptoms in DSM-IV Major Depressive Disorder: A Prospective Study. Tarja K. Melartin, MD, PhD; Jari Haukka, PhD; Heikki J. Rytsälä, MD, PhD; Pekka J. Jylhä, MD, PhD; and Erkki T. Isometsä, MD, PhD
[Abstract/Purchase] [Full Text] Posted
1/12/10
Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study. Deanna L. Kelly, PharmD, BCPP; Robert P. McMahon, PhD; Fang Liu, MS; Raymond C. Love, PharmD, BCPP; Heidi J. Wehring, PharmD, BCPP; Joo-Cheol Shim, MD, PhD; Kimberly R. Warren, PhD; and Robert R. Conley, MD
[Abstract/Purchase] [Full Text] Posted
1/12/10
Articles published electronically 12/29/09
Influence of Anesthetic Drugs and
Concurrent Psychiatric Medication on
Seizure Adequacy During Electroconvulsive Therapy. Bogata D. Bundy, MD; Walter Hewer, MD; Franz-Josef Andres, MD;
Peter Gass, MD; and Alexander Sartorius, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/29/09
Noninvasive Brain Stimulation With
High-Frequency and Low-Intensity Repetitive Transcranial Magnetic Stimulation Treatment for Posttraumatic Stress Disorder. Paulo Sergio Boggio, PhD; Martha Rocha, BSc;
Maira Okada Oliveira, BSc; Shirley Fecteau, PhD; Roni B. Cohen, MD;
Camila Campanhã, BSc; Eduardo Ferreira-Santos, MD, PhD;
Alexandrina Meleiro, MD, PhD; Felipe Corchs, MD; Soroush Zaghi, BSc;
Alvaro Pascual-Leone, MD, PhD; and Felipe Fregni, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/29/09
A Comparison of the Efficacy of Medications for
Adult Attention-Deficit/Hyperactivity Disorder
Using Meta-Analysis of Effect Sizes. Stephen V. Faraone, PhD, and Stephen J. Glatt, PhD
[Abstract/Purchase] [Full Text] Posted
12/29/09
Articles published electronically 12/15/09
Electroconvulsive Therapy Decreases Dopamine D2 Receptor Binding in the Anterior Cingulate in Patients With Depression: A Controlled Study Using Positron Emission Tomography With Radioligand [11C]FLB 457. Tomoyuki Saijo, MD, PhD; Akihiro Takano, MD, PhD; Tetsuya Suhara, MD, PhD; Ryosuke Arakawa, MD, PhD; Masaki Okumura, MD; Tetsuya Ichimiya, MD, PhD; Hiroshi Ito, MD, PhD; and Yoshiro Okubo, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Does Comorbid Posttraumatic Stress Disorder Affect the Severity and Course of Psychotic Major Depressive Disorder? Brandon A. Gaudiano, PhD, and Mark Zimmerman, MD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Levetiracetam in Generalized Social Anxiety Disorder:
A Double-Blind, Randomized Controlled Trial. Murray B. Stein, MD, MPH; Lakshmi N. Ravindran, MD;
Naomi M. Simon, MD, MSc; Michael R. Liebowitz, MD; Arifulla Khan, MD;
Olga Brawman-Mintzer, MD; R. Bruce Lydiard, MD, PhD; and Mark H. Pollack, MD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Genetic Association Study of Treatment Response
With Olanzapine/Fluoxetine Combination
or Lamotrigine in Bipolar I Depression. Roy H. Perlis, MD, MSc; David H. Adams, PhD;
Bonnie Fijal, PhD; Virginia K. Sutton, PhD; Mark Farmen, PhD;
Alan Breier, MD; and John P. Houston, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Family Outcomes From a Randomized Control Trial of Relapse Prevention Therapy in First-Episode Psychosis. John F. M. Gleeson, PhD; Sue M. Cotton, PhD;
Mario Alvarez-Jimenez, DClinPsy, PhD; Darryl Wade, PhD;
Kingsley Crisp, BSW; Belinda Newman, BA (Hons);
Daniela Spiliotacopoulos, BA; and Patrick D. McGorry, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Obesity and Onset of Significant Depressive Symptoms: Results From a Prospective Community-Based Cohort Study of Older Men and Women. Nicole Vogelzangs, MSc; Stephen B. Kritchevsky, PhD;
Aartjan T. F. Beekman, MD, PhD; Gretchen A. Brenes, MD, PhD;
Anne B. Newman, MD, PhD; Suzanne Satterfield, MD, DrPh;
Kristine Yaffe, MD; Tamara B. Harris, MD, MS; and
Brenda W. J. H. Penninx, PhD; for the Health ABC Study
[Abstract/Purchase] [Full Text] Posted
12/15/09
Associations Between Serum Lipids
and Major Depressive Disorder:
Results From the Netherlands Study of
Depression and Anxiety (NESDA). Arianne K. B. van Reedt Dortland, MSc; Erik J. Giltay, MD, PhD;
Tineke van Veen, PhD; Johannes van Pelt, PhD; Frans G. Zitman, MD, PhD;
and Brenda W. J. H. Penninx, PhD
[Abstract/Purchase] [Full Text] Posted
12/15/09
Articles published electronically 12/1/09
Relapse Prevention and Residual Symptoms:
A Closer Analysis of Placebo-Controlled Continuation Studies With Escitalopram in Major Depressive Disorder, Generalized Anxiety Disorder, Social Anxiety Disorder,
and Obsessive-Compulsive Disorder. Per Bech, MD; Sara L. Lönn, PhD; and Kerstin F. Overø, DSc (Pharm)
[Abstract/Purchase] [Full Text] Posted
12/1/09
Cigarette Smoking and Panic:
A Critical Review of the Literature. Fiammetta Cosci, MD, PhD; Inge J. E. Knuts, MD; Kenneth Abrams, PhD;
Eric J. L. Griez, MD, PhD; and Koen R. J. Schruers, MD, PhD
[Abstract/Purchase] [Full Text] Posted
12/1/09
Comorbid Substance Use Disorders Among Youth
With Bipolar Disorder: Opportunities for
Early Identification and Prevention. Benjamin I. Goldstein, MD, PhD, and Oscar G. Bukstein, MD, MPH
[Abstract/Purchase] [Full Text] Posted
12/1/09
Articles published electronically 11/17/09
Beliefs About Voices and Aggressive Behavior
in Inpatients in an Acute Psychiatric Setting. Brady A. Berman, MA; Kristine Duffy, PhD; and Mark R. Serper, PhD
[Abstract/Purchase] [Full Text] Posted
11/17/09
First-Year Medicare Part D Prescription Drug Benefits:
Medication Access and Continuity Among
Dual Eligible Psychiatric Patients. Joyce C. West, PhD, MPP; Joshua E. Wilk, PhD; Donald S. Rae, MS;
Irvin L. Muszynski, JD; Maritza Rubio-Stipec, ScD; Carol L. Alter, MD;
Karen E. Sanders, MS; Stephen Crystal, PhD; and Darrel A. Regier, MD, MPH
[Abstract/Purchase] [Full Text] Posted
11/17/09
Neurocognitive Impairment and Psychosis
in Bipolar I Disorder During Early Remission
From an Acute Episode of Mood Disturbance. Boaz Levy, PhD, and Roger D. Weiss, MD
[Abstract/Purchase] [Full Text] Posted
11/17/09
Articles published electronically 11/3/09
Antipsychotic Polypharmacy and Risk of Death From Natural Causes in Patients With Schizophrenia: A Population-Based Nested Case-Control Study. Lone Baandrup, MD; Christiane Gasse, RPharm, PhD;
Vibeke D. Jensen, RPharm; Birte Y. Glenthoj, MD, DMSc;
Merete Nordentoft, MD, PhD, DMSc; Henrik Lublin, MD, DMSc;
Anders Fink-Jensen, MD, DMSc; Anne Lindhardt, MD;
and Preben B. Mortensen, MD, DMSc
[Abstract/Purchase] [Full Text] Posted
11/3/09
A Double-Blind, Randomized Study of Minocycline
for the Treatment of Negative and Cognitive Symptoms
in Early-Phase Schizophrenia. Yechiel Levkovitz, MD; Shlomo Mendlovich, MD; Sharon Riwkes;
Yoram Braw, PhD; Hana Levkovitch-Verbin, MD; Gilad Gal, PhD;
Shmuel Fennig, MD; Ilan Treves, MD; and Shmuel Kron, MD
[Abstract/Purchase] [Full Text] Posted
11/3/09
Prevalence of Negative Symptoms in
Outpatients With Schizophrenia Spectrum Disorders
Treated With Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS Study. Julio Bobes, MD, PhD; Celso Arango, MD, PhD;
Margarida Garcia-Garcia, MSc; and Javier Rejas, MD, PhD;
for the CLAMORS Study Collaborative Group
[Abstract/Purchase] [Full Text] Posted
11/3/09
Articles published electronically 10/20/09
Loss of Control Over Eating Predicts Outcomes in Bariatric Surgery Patients: A Prospective, 24-Month Follow-Up Study. Marney A. White, PhD; Melissa A. Kalarchian, PhD; Robin M. Masheb, PhD; Marsha D. Marcus, PhD; and Carlos M. Grilo, PhD
[Abstract/Purchase] [Full Text] Posted
10/20/09
Articles published electronically 10/6/09
Easy and Low-Cost Identification of Metabolic Syndrome in Patients Treated With Second-Generation Antipsychotics: Artificial Neural Network and Logistic Regression Models. Chao-Cheng Lin, MD, PhD; Ya-Mei Bai, MD, PhD; Jen-Yeu Chen, MD; Tzung-Jeng Hwang, MD; Tzu-Ting Chen, MD; Hung-Wen Chiu, PhD; and Yu-Chuan Li, MD, PhD
[Abstract/Purchase] [Full Text] Posted
10/6/09
Articles published electronically 8/25/09
Baseline Characteristics and Outcomes in Patients With First Episode or Multiple Episodes of Acute Mania. Mauricio Tohen, MD, DrPH, MBA; Eduard Vieta, MD, PhD; Ana Gonzalez-Pinto, MD; Catherine Reed, MS; and Daniel Lin, PhD; for the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board
[Abstract/Purchase] [Full Text] Posted
8/25/09
Online
Poll
Psychiatrist.com Home
Keyword Search
JCP Online Forum
